The role of long noncoding RNA H19 in gynecological pathologies: Insights into gene regulation and immune modulation (Review)
- Authors:
- Weijuan Xin
- Yue Wang
- Keqin Hua
- Songping Liu
-
Affiliations: Department of Obstetrics and Gynecology, Obstetrics and Gynecology Hospital of Fudan University, Shanghai 200090, P.R. China, Department of Obstetrics and Gynecology, Jinshan Hospital of Fudan University, Shanghai 201508, P.R. China - Published online on: July 7, 2023 https://doi.org/10.3892/ijmm.2023.5276
- Article Number: 73
-
Copyright: © Xin et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
 |
 |
 |
 |
 |
 |
|
Li D, Zhang J, Li X, Chen Y, Yu F and Liu Q: Insights into lncRNAs in Alzheimer's disease mechanisms. RNA Biol. 18:1037–1047. 2021. View Article : Google Scholar | |
|
Zhu L, Li N, Sun L, Zheng D and Shao G: Non-coding RNAs: The key detectors and regulators in cardiovascular disease. Genomics. 113:1233–1246. 2021. View Article : Google Scholar | |
|
Lu Q, Guo P, Liu A, Ares I, Martínez-Larrañaga MR, Wang X, Anadón A and Martínez MA: The role of long noncoding RNA in lipid, cholesterol, and glucose metabolism and treatment of obesity syndrome. Med Res Rev. 41:1751–1774. 2021. View Article : Google Scholar | |
|
Ferlita A, Battaglia R, Andronico F, Caruso S, Cianci A, Purrello M and Pietro CD: Non-coding RNAs in endometrial physiopathology. Int J Mol Sci. 19:21202018. View Article : Google Scholar : PubMed/NCBI | |
|
Statello L, Guo CJ, Chen LL and Huarte M: Gene regulation by long non-coding RNAs and its biological functions. Nat Rev Mol Cell Biol. 22:96–118. 2021. View Article : Google Scholar | |
|
Bin X, Hongjian Y, Xiping Z, Bo C, Shifeng Y and Binbin T: Research progresses in roles of LncRNA and its relationships with breast cancer. Cancer Cell Int. 18:1792018. View Article : Google Scholar : PubMed/NCBI | |
|
Liau WS, Samaddar S, Banerjee S and Bredy TW: On the functional relevance of spatiotemporally-specific patterns of experience-dependent long noncoding RNA expression in the brain. RNA Biol. 18:1025–1036. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Yarani R, Mirza AH, Kaur S and Pociot F: The emerging role of lncRNAs in inflammatory bowel disease. Exp Mol Med. 50:1–14. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Peng H, Wan LY, Liang JJ, Zhang YQ, Ai WB and Wu JF: The roles of lncRNA in hepatic fibrosis. Cell Biosci. 8:632018. View Article : Google Scholar : PubMed/NCBI | |
|
Jantrapirom S, Koonrungsesomboon N, Yoshida H, M Candeias M, Pruksakorn D and Lo Piccolo L: Long noncoding RNA-dependent methylation of nonhistone proteins. Wiley Interdiscip Rev RNA. 12:e16612021. View Article : Google Scholar : PubMed/NCBI | |
|
Khalili-Tanha G and Moghbeli M: Long non-coding RNAs as the critical regulators of doxorubicin resistance in tumor cells. Cell Mol Biol Lett. 26:392021. View Article : Google Scholar : PubMed/NCBI | |
|
Cabili MN, Trapnell C, Goff L, Koziol M, Tazon-Vega B, Regev A and Rinn JL: Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses. Genes Dev. 25:1915–1927. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Li N, Zhang H, Hu K and Chu J: A novel long non-coding RNA-based prognostic signature for renal cell carcinoma patients with stage IV and histological grade G4. Bioengineered. 12:6275–6285. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Bo C, Li N, He L, Zhang S and An Y: Long non-coding RNA ILF3-AS1 facilitates hepatocellular carcinoma progression by stabilizing ILF3 mRNA in an m6A-dependent manner. Hum Cell. 34:1843–1854. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Luo Y, Ge P, Wang M and Chen H, Liu J, Wei T, Jiang Y, Qu J and Chen H: Research progress of DLX6-AS1 in human cancers. Hum Cell. 34:1642–1652. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Ma L, Bajic VB and Zhang Z: On the classification of long non-coding RNAs. RNA Biol. 10:925–933. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Bhatti GK, Khullar N, Sidhu IS, Navik US, Reddy AP, Reddy PH and Bhatti JS: Emerging role of non-coding RNA in health and disease. Metab Brain Dis. 36:1119–1134. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Nojima T and Proudfoot NJ: Mechanisms of lncRNA biogenesis as revealed by nascent transcriptomics. Nat Rev Mol Cell Biol. 23:389–406. 2022. View Article : Google Scholar : PubMed/NCBI | |
|
Yan W, Hu H and Tang B: Progress in understanding the relationship between long noncoding RNA and endometriosis. Eur J Obstet Gynecol Reprod Biol X. 5:1000672019. View Article : Google Scholar | |
|
Constanty F and Shkumatava A: lncRNAs in development and differentiation: From sequence motifs to functional characterization. Development. 148:dev1827412021. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang H, Bian C, Tu S, Yin F, Guo P, Zhang J, Song X, Liu Q, Chen C and Han Y: Integrated analysis of lncRNA-miRNA-mRNA ceRNA network in human aortic dissection. BMC Genomics. 22:7242021. View Article : Google Scholar : PubMed/NCBI | |
|
Li J, Qian Y, Zhang C, Wang W, Qiao Y, Song H, Li L, Guo J, Lu D and Deng X: LncRNA LINC00473 is involved in the progression of invasive pituitary adenoma by upregulating KMT5A via ceRNA-mediated miR-502-3p evasion. Cell Death Dis. 12:5802021. View Article : Google Scholar : PubMed/NCBI | |
|
Irwin AB, Bahabry R and Lubin FD: A putative role for lncRNAs in epigenetic regulation of memory. Neurochem Int. 150:1051842021. View Article : Google Scholar : PubMed/NCBI | |
|
Chen X, Xie R, Gu P, Huang M, Han J, Dong W, Xie W, Wang B, He W, Zhong G, et al: Long noncoding RNA LBCS inhibits self-renewal and chemoresistance of bladder cancer stem cells through epigenetic silencing of SOX2. Clin Cancer Res. 25:1389–1403. 2019. View Article : Google Scholar | |
|
Wang D, Sun Y, Lin L, Sang Y, Yang F, Zhang J, Jia L, Xu Z and Zhang W: Long non-coding RNA H19 and the underlying epigenetic function in response to DNA damage of lung cancer cells. Am J Transl Res. 13:5835–5850. 2021.PubMed/NCBI | |
|
Hernández-Aguilar AI, Luciano-Villa CA, Tello-Flores VA, Beltrán-Anaya FO, Zubillaga-Guerrero MI and Flores-Alfaro E: Dysregulation of lncRNA-H19 in cardiometabolic diseases and the molecular mechanism involved: A systematic review. Expert Rev Mol Diagn. 21:809–821. 2021. View Article : Google Scholar | |
|
Matsuzaki H, Okamura E, Takahashi T, Ushiki A, Nakamura T, Nakano T, Hata K, Fukamizu A and Tanimoto K: De novo DNA methylation through the 5′-segment of the H19 ICR maintains its imprint during early embryogenesis. Development. 142:3833–3844. 2015.PubMed/NCBI | |
|
Gabory A, Jammes H and Dandolo L: The H19 locus: role of an imprinted non-coding RNA in growth and development. Bioessays. 32:473–480. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Wang J, Sun J and Yang F: The role of long non-coding RNA H19 in breast cancer. Oncol Lett. 19:7–16. 2020.PubMed/NCBI | |
|
Wang Y and Gao WJ: Long non-coding RNA-H19 promotes ovarian cancer cell proliferation and migration via the microRNA-140/Wnt1 axis. Kaohsiung J Med Sci. 37:768–775. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Li Y, Zhang Y, Hu Q, Egranov SD, Xing Z, Zhang Z, Liang K, Ye Y, Pan Y, Chatterjee SS, et al: Functional significance of gain-of-function H19 lncRNA in skeletal muscle differentiation and anti-obesity effects. Genome Med. 13:1372021. View Article : Google Scholar : PubMed/NCBI | |
|
Wang L and Qi L: The role and mechanism of long non-coding RNA H19 in stem cell osteogenic differentiation. Mol Med. 27:862021. View Article : Google Scholar : PubMed/NCBI | |
|
Su W, Huo Q, Wu H, Wang L, Ding X, Liang L, Zhou L, Zhao Y, Dan J and Zhang H: The function of LncRNA-H19 in cardiac hypertrophy. Cell Biosci. 11:1532021. View Article : Google Scholar : PubMed/NCBI | |
|
Tian X, Wang Y, Lu Y, Wang W, Du J, Chen S, Zhou H, Cai W and Xiao Y: Conditional depletion of macrophages ameliorates cholestatic liver injury and fibrosis via lncRNA-H19. Cell Death Dis. 12:6462021. View Article : Google Scholar : PubMed/NCBI | |
|
Ghafouri-Fard S, Esmaeili M and Taheri M: H19 lncRNA: Roles in tumorigenesis. Biomed Pharmacother. 123:1097742020. View Article : Google Scholar | |
|
Yang J, Qi M, Fei X, Wang X and Wang K: LncRNA H19: A novel oncogene in multiple cancers. Int J Biol Sci. 17:3188–3208. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Shermane Lim YW, Xiang X, Garg M, Le MT, Li-Ann Wong A, Wang L and Goh BC: The double-edged sword of H19 lncRNA: Insights into cancer therapy. Cancer Lett. 500:253–262. 2021. View Article : Google Scholar | |
|
Wei LQ, Li L, Lu C, Liu J, Chen Y and Wu H: Involvement of H19/miR-326 axis in hepatocellular carcinoma development through modulating TWIST1. J Cell Physiol. 234:5153–5162. 2019. View Article : Google Scholar | |
|
Ye Y, Guo J, Xiao P, Ning J, Zhang R, Liu P, Yu W, Xu L, Zhao Y and Yu J: Macrophages-induced long noncoding RNA H19 up-regulation triggers and activates the miR-193b/MAPK1 axis and promotes cell aggressiveness in hepatocellular carcinoma. Cancer Lett. 469:310–322. 2020. View Article : Google Scholar | |
|
Li CF, Li YC, Wang Y and Sun LB: The effect of LncRNA H19/miR-194-5p axis on the epithelial-mesenchymal transition of colorectal adenocarcinoma. Cell Physiol Biochem. 50:196–213. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Ding D, Li C, Zhao T, Li D, Yang L and Zhang B: LncRNA H19/miR-29b-3p/PGRN axis promoted epithelial-mesenchymal transition of colorectal cancer cells by acting on Wnt signaling. Mol Cells. 41:423–435. 2018.PubMed/NCBI | |
|
Chen S, Bu D, Ma Y, Zhu J, Chen G, Sun L, Zuo S, Li T, Pan Y, Wang X, et al: H19 overexpression induces resistance to 1,25(OH)2D3 by targeting VDR through miR-675-5p in colon cancer cells. Neoplasia. 19:226–236. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Lv M, Zhong Z, Huang M, Tian Q, Jiang R and Chen J: lncRNA H19 regulates epithelial-mesenchymal transition and metastasis of bladder cancer by miR-29b-3p as competing endogenous RNA. Biochim Biophys Acta Mol Cell Res. 1864:1887–1899. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Xiong H, Shen J, Chen Z, Yang J, Xie B, Jia Y, Jayasinghe U, Wang J, Zhao W, Xie S, et al: H19/let-7/Lin28 ceRNA network mediates autophagy inhibiting epithelial-mesenchymal transition in breast cancer. Int J Oncol. 56:794–806. 2020.PubMed/NCBI | |
|
Zhao W, Lin X, Han H, Zhang H, Li X, Jiang C and Feng M: Long noncoding RNA H19 contributes to the proliferation and autophagy of glioma cells through mTOR/ULK1 pathway. Neuroreport. 32:352–358. 2021.PubMed/NCBI | |
|
Luan W, Zhou Z, Ni X, Xia Y, Wang J, Yan Y and Xu B: Long non-coding RNA H19 promotes glucose metabolism and cell growth in malignant melanoma via miR-106a-5p/E2F3 axis. J Cancer Res Clin Oncol. 144:531–542. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Zheng ZH, Wu DM, Fan SH, Zhang ZF, Chen GQ and Lu J: Upregulation of miR-675-5p induced by lncRNA H19 was associated with tumor progression and development by targeting tumor suppressor p53 in non-small cell lung cancer. J Cell Biochem. 120:18724–18735. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Sun L, Li J, Yan W, Yao Z, Wang R, Zhou X, Wu H, Zhang G, Shi T and Chen W: H19 promotes aerobic glycolysis, proliferation, and immune escape of gastric cancer cells through the microRNA-519d-3p/lactate dehydrogenase A axis. Cancer Sci. 112:2245–2259. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
He H, Wang N, Yi X, Tang C and Wang D: Long non-coding RNA H19 regulates E2F1 expression by competitively sponging endogenous miR-29a-3p in clear cell renal cell carcinoma. Cell Biosci. 7:652017. View Article : Google Scholar : PubMed/NCBI | |
|
Zhao TF, Jia HZ, Zhang ZZ, Zhao XS, Zou YF, Zhang W, Wan J and Chen XF: LncRNA H19 regulates ID2 expression through competitive binding to hsa-miR-19a/b in acute myelocytic leukemia. Mol Med Rep. 16:3687–3693. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Sun Y, Zhu Q, Yang W, Shan Y, Yu Z, Zhang Q and Wu H: LncRNA H19/miR-194/PFTK1 axis modulates the cell proliferation and migration of pancreatic cancer. J Cell Biochem. 120:3874–3886. 2019. View Article : Google Scholar | |
|
Zhu M, Chen Q, Liu X, Sun Q, Zhao X, Deng R, Wang Y, Huang J, Xu M, Yan J and Yu J: lncRNA H19/miR-675 axis represses prostate cancer metastasis by targeting TGFBI. FEBS J. 281:3766–3775. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang L, Yang F, Yuan JH, Yuan SX, Zhou WP, Huo XS, Xu D, Bi HS, Wang F and Sun SH: Epigenetic activation of the MiR-200 family contributes to H19-mediated metastasis suppression in hepatocellular carcinoma. Carcinogenesis. 34:577–586. 2013. View Article : Google Scholar | |
|
Fang Y, Hu J, Wang Z, Zong H, Zhang L, Zhang R and Sun L: LncRNA H19 functions as an aquaporin 1 competitive endogenous RNA to regulate microRNA-874 expression in LPS sepsis. Biomed Pharmacother. 105:1183–1191. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Lu Q, Guo Z, Xie W, Jin W, Zhu D, Chen S and Ren T: The lncRNA H19 mediates pulmonary fibrosis by regulating the miR-196a/COL1A1 axis. Inflammation. 41:896–903. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Song Y, Liu C, Liu X, Trottier J, Beaudoin M, Zhang L, Pope C, Peng G, Barbier O, Zhong X, et al: H19 promotes cholestatic liver fibrosis by preventing ZEB1-mediated inhibition of epithelial cell adhesion molecule. Hepatology. 66:1183–1196. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
You L, Lv Z, Li C, Ye W, Zhou Y, Jin J and Han Q: Worldwide cancer statistics of adolescents and young adults in 2019: A systematic analysis of the global burden of disease study 2019. ESMO Open. 6:1002552021. View Article : Google Scholar | |
|
Hoppe-Seyler F and Hoppe-Seyler K: Emerging topics in human tumor virology. Int J Cancer. 129:1289–1299. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Gibb EA, Becker-Santos DD, Enfield KS, Guillaud M, Niekerk Dv, Matisic JP, Macaulay CE and Lam WL: Aberrant expression of long noncoding RNAs in cervical intraepithelial neoplasia. Int J Gynecol Cancer. 22:1557–1563. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Zhong Q, Lu M, Yuan W, Cui Y, Ouyang H, Fan Y, Wang Z, Wu C, Qiao J and Hang J: Eight-lncRNA signature of cervical cancer were identified by integrating DNA methylation, copy number variation and transcriptome data. J Transl Med. 19:582021. View Article : Google Scholar : PubMed/NCBI | |
|
Kim SJ, Park SE, Lee C, Lee SY, Jo JH, Kim JM and Oh YK: Alterations in promoter usage and expression levels of insulin-like growth factor-II and H19 genes in cervical carcinoma exhibiting biallelic expression of IGF-II. Biochim Biophys Acta. 1586:307–315. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Iempridee T: Long non-coding RNA H19 enhances cell proliferation and anchorage-independent growth of cervical cancer cell lines. Exp Biol Med (Maywood). 242:184–193. 2017. View Article : Google Scholar | |
|
Ou L, Wang D, Zhang H, Yu Q and Hua F: Decreased expression of miR-138-5p by lncRNA H19 in cervical cancer promotes tumor proliferation. Oncol Res. 26:401–410. 2018. View Article : Google Scholar | |
|
Peng L, Yuan XQ, Liu ZY, Li WL, Zhang CY, Zhang YQ, Pan X, Chen J, Li YH and Li GC: High lncRNA H19 expression as prognostic indicator: Data mining in female cancers and polling analysis in non-female cancers. Oncotarget. 8:1655–1667. 2017. View Article : Google Scholar : | |
|
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 71:209–249. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Takenaka K, Chen BJ, Modesitt SC, Byrne FL, Hoehn KL and Janitz M: The emerging role of long non-coding RNAs in endometrial cancer. Cancer Genet. 209:445–455. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Urick ME and Bell DW: Clinical actionability of molecular targets in endometrial cancer. Nat Rev Cancer. 19:510–521. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Brooks RA, Fleming GF, Lastra RR, Lee NK, Moroney JW, Son CH, Tatebe K and Veneris JL: Current recommendations and recent progress in endometrial cancer. CA Cancer J Clin. 69:258–279. 2019.PubMed/NCBI | |
|
Xu J, Qian Y, Ye M, Fu Z, Jia X, Li W, Xu P, Lv M, Huang L, Wang L, et al: Distinct expression profile of lncRNA in endometrial carcinoma. Oncol Rep. 36:3405–3412. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Smolle MA, Bullock MD, Ling H, Pichler M and Haybaeck J: Long non-coding RNAs in endometrial carcinoma. Int J Mol Sci. 16:26463–26472. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Vallone C, Rigon G, Gulia C, Baffa A, Votino R, Morosetti G, Zaami S, Briganti V, Catania F, Gaffi M, et al: Non-coding RNAs and endometrial cancer. Genes (Basel). 9:1872018. View Article : Google Scholar : PubMed/NCBI | |
|
Tanos V, Ariel I, Prus D, De-Groot N and Hochberg A: H19 and IGF2 gene expression in human normal, hyperplastic, and malignant endometrium. Int J Gynecol Cancer. 14:521–525. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang L, Wang DL and Yu P: LncRNA H19 regulates the expression of its target gene HOXA10 in endometrial carcinoma through competing with miR-612. Eur Rev Med Pharmacol Sci. 22:4820–4827. 2018.PubMed/NCBI | |
|
Zhao L, Li Z, Chen W, Zhai W, Pan J, Pang H and Li X: H19 promotes endometrial cancer progression by modulating epithelial-mesenchymal transition. Oncol Lett. 13:363–369. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Ahmed ZSO, Golovoy M, Abdullah Y, Ahmed RSI and Dou QP: Repurposing of metformin for cancer therapy: Updated patent and literature review. Recent Pat Anticancer Drug Discov. 16:161–186. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Yan L, Zhou J, Gao Y, Ghazal S, Lu L, Bellone S, Yang Y, Liu N, Zhao X, Santin AD, et al: Regulation of tumor cell migration and invasion by the H19/let-7 axis is antagonized by metformin-induced DNA methylation. Oncogene. 34:3076–3084. 2015. View Article : Google Scholar | |
|
Lu YM, Wang Y, Liu SQ, Zhou MY and Guo YR: Profile and validation of dysregulated long non-coding RNAs and mRNAs in ovarian cancer. Oncol Rep. 40:2964–2976. 2018.PubMed/NCBI | |
|
Lou Y, Jiang H, Cui Z, Wang X, Wang L and Han Y: Gene microarray analysis of lncRNA and mRNA expression profiles in patients with high-grade ovarian serous cancer. Int J Mol Med. 42:91–104. 2018.PubMed/NCBI | |
|
Zhong Y, Gao D, He S, Shuai C and Peng S: Dysregulated expression of long noncoding RNAs in ovarian cancer. Int J Gynecol Cancer. 26:1564–1570. 2016. View Article : Google Scholar : PubMed/NCBI | |
|
Ren C, Li X, Wang T, Wang G, Zhao C, Liang T, Zhu Y, Li M, Yang C, Zhao Y and Zhang GM: Functions and mechanisms of long noncoding RNAs in ovarian cancer. Int J Gynecol Cancer. 25:566–569. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Xu J, Wu J, Fu C, Teng F, Liu S, Dai C, Shen R and Jia X: Multidrug resistant lncRNA profile in chemotherapeutic sensitive and resistant ovarian cancer cells. J Cell Physiol. 233:5034–5043. 2018. View Article : Google Scholar | |
|
Chen CL, Ip SM, Cheng D, Wong LC and Ngan HY: Loss of imprinting of the IGF-II and H19 genes in epithelial ovarian cancer. Clin Cancer Res. 6:474–479. 2000.PubMed/NCBI | |
|
Zhu Z, Song L, He J, Sun Y, Liu X and Zou X: Ectopic expressed long non-coding RNA H19 contributes to malignant cell behavior of ovarian cancer. Int J Clin Exp Pathol. 8:10082–10091. 2015.PubMed/NCBI | |
|
Li J, Huang Y, Deng X, Luo M, Wang X, Hu H, Liu C and Zhong M: Long noncoding RNA H19 promotes transforming growth factor-β-induced epithelial-mesenchymal transition by acting as a competing endogenous RNA of miR-370-3p in ovarian cancer cells. Onco Targets Ther. 11:427–440. 2018. View Article : Google Scholar : | |
|
Tian X, Zuo X, Hou M, Li C and Teng Y: LncRNA-H19 regulates chemoresistance to carboplatin in epithelial ovarian cancer through microRNA-29b-3p and STAT3. J Cancer. 12:5712–5722. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Sajadpoor Z, Amini-Farsani Z, Teimori H, Shamsara M, Sangtarash MH, Ghasemi-Dehkordi P and Yadollahi F: Valproic acid promotes apoptosis and cisplatin sensitivity through downregulation of H19 noncoding RNA in ovarian A2780 cells. Appl Biochem Biotechnol. 185:1132–1144. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Zheng X, Zhou Y, Chen W, Chen L, Lu J, He F, Li X and Zhao L: Ginsenoside 20(S)-Rg3 prevents PKM2-targeting miR-324-5p from H19 sponging to antagonize the warburg effect in ovarian cancer cells. Cell Physiol Biochem. 51:1340–1353. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Hansen S, Sverrisdóttir UÁ and Rudnicki M: Impact of exercise on pain perception in women with endometriosis: A systematic review. Acta Obstet Gynecol Scand. 100:1595–1601. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Liu S, Xin W, Lu Q, Tang X, Wang F, Shao W, Zhang Y, Qiu J and Hua K: Knockdown of lncRNA H19 suppresses endometriosis in vivo. Braz J Med Biol Res. 54:e101172021. View Article : Google Scholar : PubMed/NCBI | |
|
Panir K, Schjenken JE, Robertson SA and Hull ML: Non-coding RNAs in endometriosis: A narrative review. Hum Reprod Update. 24:497–515. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Cui D, Ma J, Liu Y, Lin K, Jiang X, Qu Y, Lin J and Xu K: Analysis of long non-coding RNA expression profiles using RNA sequencing in ovarian endometriosis. Gene. 673:140–148. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Wu J, Huang H, Huang W, Wang L, Xia X and Fang X: Analysis of exosomal lncRNA, miRNA and mRNA expression profiles and ceRNA network construction in endometriosis. Epigenomics. 12:1193–1213. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Wang Y, Li Y, Yang Z, Liu K and Wang D: Genome-wide microarray analysis of long non-coding RNAs in eutopic secretory endometrium with endometriosis. Cell Physiol Biochem. 37:2231–2245. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Wang WT, Sun YM, Huang W, He B, Zhao YN and Chen YQ: Genome-wide long non-coding RNA analysis identified circulating LncRNAs as novel non-invasive diagnostic biomarkers for gynecological disease. Sci Rep. 6:233432016. View Article : Google Scholar : PubMed/NCBI | |
|
Lin D, Huang Q, Wu R, Dai S, Huang Z, Ren L, Huang S and Chen Q: Long non-coding RNA AFAP1-AS1 promoting epithelial-mesenchymal transition of endometriosis is correlated with transcription factor ZEB1. Am J Reprod Immunol. 81:e130742019. View Article : Google Scholar | |
|
Liu H, Zhang Z, Xiong W, Zhang L, Du Y, Liu Y and Xiong X: Long non-coding RNA MALAT1 mediates hypoxia-induced pro-survival autophagy of endometrial stromal cells in endometriosis. J Cell Mol Med. 23:439–452. 2019. View Article : Google Scholar | |
|
Liu J, Wang Q, Zhang R, Zhang C, Lin J and Huang X: Identification of LINC01279 as a cell cycle-associated long non-coding RNA in endometriosis with GBA analysis. Mol Med Rep. 18:3850–3858. 2018.PubMed/NCBI | |
|
Huan Q, Cheng SC, Du ZH, Ma HF and Li C: LncRNA AFAP1-AS1 regulates proliferation and apoptosis of endometriosis through activating STAT3/TGF-β/Smad signaling via miR-424-5p. J Obstet Gynaecol Res. 47:2394–2405. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Liu S, Qiu J, Tang X, Cui H, Zhang Q and Yang Q: LncRNA-H19 regulates cell proliferation and invasion of ectopic endometrium by targeting ITGB3 via modulating miR-124-3p. Exp Cell Res. 381:215–222. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Xu Z, Zhang L, Yu Q, Zhang Y, Yan L and Chen ZJ: The estrogen-regulated lncRNA H19/miR-216a-5p axis alters stromal cell invasion and migration via ACTA2 in endometriosis. Mol Hum Reprod. 25:550–561. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Liu S, Xin W, Tang X, Qiu J, Zhang Y and Hua K: LncRNA H19 overexpression in endometriosis and its utility as a novel biomarker for predicting recurrence. Reprod Sci. 27:1687–1697. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Liu Z, Liu L, Zhong Y, Cai M, Gao J, Tan C, Han X, Guo R and Han L: LncRNA H19 over-expression inhibited Th17 cell differentiation to relieve endometriosis through miR-342-3p/IER3 pathway. Cell Biosci. 9:842019. View Article : Google Scholar : PubMed/NCBI | |
|
Wang Y, Hu T, Wu L, Liu X, Xue S and Lei M: Identification of non-coding and coding RNAs in porcine endometrium. Genomics. 109:43–50. 2017. View Article : Google Scholar | |
|
Wang Y, Hua R, Xue S, Li W, Wu L, Kang T and Lei M: mRNA/lncRNA expression patterns and the function of fibrinogen-like protein 2 in Meishan pig endometrium during the preimplantation phases. Mol Reprod Dev. 86:354–369. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Chen MY, Liao GD, Zhou B, Kang LN, He YM and Li SW: Genome-wide profiling of long noncoding RNA expression patterns in women with repeated implantation failure by RNA sequencing. Reprod Sci. 26:18–25. 2019. View Article : Google Scholar | |
|
Huang J, Song N, Xia L, Tian L, Tan J, Chen Q, Zhu J and Wu Q: Construction of lncRNA-related competing endogenous RNA network and identification of hub genes in recurrent implantation failure. Reprod Biol Endocrinol. 19:1082021. View Article : Google Scholar : PubMed/NCBI | |
|
Feng C, Shen JM, Lv PP, Jin M, Wang LQ, Rao JP and Feng L: Construction of implantation failure related lncRNA-mRNA network and identification of lncRNA biomarkers for predicting endometrial receptivity. Int J Biol Sci. 14:1361–1377. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Ariel I, Weinstein D, Voutilainen R, Schneider T, Lustig-Yariv O, de Groot N and Hochberg A: Genomic imprinting and the endometrial cycle. The expression of the imprinted gene H19 in the human female reproductive organs. Diagn Mol Pathol. 6:17–25. 1997. View Article : Google Scholar : PubMed/NCBI | |
|
Korucuoglu U, Biri AA, Konac E, Alp E, Onen IH, Ilhan MN, Turkyilmaz E, Erdem A, Erdem M and Menevse S: Expression of the imprinted IGF2 and H19 genes in the endometrium of cases with unexplained infertility. Eur J Obstet Gynecol Reprod Biol. 149:77–81. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Zeng H, Fan X and Liu N: Expression of H19 imprinted gene in patients with repeated implantation failure during the window of implantation. Arch Gynecol Obstet. 296:835–839. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Wang H, Cao Q, Ge J, Liu C, Ma Y, Meng Y, Wang Y, Zhao X, Liu R, Li C, et al: LncRNA-regulated infection and inflammation pathways associated with pregnancy loss: Genome wide differential expression of lncRNAs in early spontaneous abortion. Am J Reprod Immunol. 72:359–375. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
He D, Zeng H, Chen J, Xiao L, Zhao Y and Liu N: H19 regulates trophoblastic spheroid adhesion by competitively binding to let-7. Reproduction. 157:423–430. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Hu L, Zeng H and Liu N: Expression of H19 long non-coding RNA and ZEB1 in the trophoblast of women with spontaneous abortion. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 43:179–183. 2018.In Chinese. PubMed/NCBI | |
|
Bai RX and Tang ZY: Long non-coding RNA H19 regulates Bcl-2, Bax and phospholipid hydroperoxide glutathione peroxidase expression in spontaneous abortion. Exp Ther Med. 21:412021. View Article : Google Scholar | |
|
Li J, Han T, Wang X, Wang Y, Chen X, Chen W and Yang Q: H19 may regulate the immune cell infiltration in carcinogenesis of gastric cancer through miR-378a-5p/SERPINH1 signaling. World J Surg Oncol. 20:2952022. View Article : Google Scholar : PubMed/NCBI | |
|
Sahin Y: LncRNA H19 is a potential biomarker and correlated with immune infiltration in thyroid carcinoma. Clin Exp Med. 23:841–851. 2023. View Article : Google Scholar | |
|
Chen X, Luo X, Wei Y, Sun H, Dai L, Tangzhou Y, Jin H and Yin Z: LncRNA H19 induces immune dysregulation of BMMSCs, at least partly, by inhibiting IL-2 production. Mol Med. 27:612021. View Article : Google Scholar : PubMed/NCBI | |
|
Li X, Wang H, Zhang Y, Zhang J, Qi S, Zhang Y and Gao MQ: Overexpression of lncRNA H19 changes basic characteristics and affects immune response of bovine mammary epithelial cells. PeerJ. 7:e67152019. View Article : Google Scholar : PubMed/NCBI | |
|
Yang S, Fang F, Yu X, Yang C, Zhang X, Wang L, Zhu L, Shao K and Zhu T: Knockdown of H19 inhibits the pathogenesis of acne vulgaris by targeting the miR-196a/TLR2/NF-κB axis. Inflammation. 43:1936–1947. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Wang B, Suen CW, Ma H, Wang Y, Kong L, Qin D, Lee YWW and Li G: The roles of H19 in regulating inflammation and aging. Front Immunol. 11:5796872020. View Article : Google Scholar : PubMed/NCBI | |
|
Hashemi M, Moosavi MS, Abed HM, Dehghani M, Aalipour M, Heydari EA, Behroozaghdam M, Entezari M, Salimimoghadam S, Gunduz ES, et al: Long non-coding RNA (lncRNA) H19 in human cancer: From proliferation and metastasis to therapy. Pharmacol Res. 184:1064182022. View Article : Google Scholar : PubMed/NCBI | |
|
Ye Y, Shen A and Liu A: Long non-coding RNA H19 and cancer: A competing endogenous RNA. Bull Cancer. 106:1152–1159. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Alipoor B, Parvar SN, Sabati Z, Ghaedi H and Ghasemi H: An updated review of the H19 lncRNA in human cancer: Molecular mechanism and diagnostic and therapeutic importance. Mol Biol Rep. 47:6357–6374. 2020. View Article : Google Scholar : PubMed/NCBI |
